BIOC RESE : Bionaturis shares start quoting in the continuous system on the MAB

Shares of Bionaturis (BNT-MB), an international reference company developing biological drugs, will start quoting from next 23 June in the continuous system instead of fixing (with two auctions per day) on the MAB. So that, Bionaturis' shares will be available to buy and sell at any moment of each trading session.

It´s a new achievement after its recent increase of capital with 76% of oversubscription. Since its opening session on the MAB, BNT shares price has increased 330%, while the liquidity of the value has increased progressively.

According to Victor Infante, Bionaturis' CEO, "this is a new milestone on our path in response to what investors were asking for. We have confidence that this measure will allow new qualified stakeholders who understand the business and want to make history with us to be on board. Trading by the continuous system means opening the door to specialized investment funds, both national and abroad, that will contribute to consolidate our growth".